Go Pro
NASDAQ:HQY

HealthEquity (HQY) Stock Price, News & Analysis

HealthEquity logo
$104.63 +1.19 (+1.15%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$104.72 +0.09 (+0.09%)
As of 08/7/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About HealthEquity Stock (NASDAQ:HQY)

Advanced

Key Stats

Today's Range
$103.18
$105.40
50-Day Range
$83.43
$104.97
52-Week Range
$72.76
$106.42
Volume
537,548 shs
Average Volume
737,996 shs
Market Capitalization
$8.75 billion
P/E Ratio
39.19
Dividend Yield
N/A
Price Target
$110.93
Consensus Rating
Moderate Buy

Company Overview

HealthEquity, Inc. (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions. In 2020, the company expanded its suite of offerings through the acquisition of WageWorks, broadening its reach into commuter and lifestyle benefits. HealthEquity’s digital platform features online tools, mobile applications and customer support to simplify enrollment, claims processing and regulatory compliance for plan sponsors and participants.

HealthEquity is led by Chief Executive Officer Jon Kessler, supported by founder and Executive Chairman Stephen Nee. Under their stewardship, the company has focused on product innovation, strategic partnerships and operational efficiency to deliver scalable benefits solutions. HealthEquity continues to invest in technology enhancements and integrations aimed at empowering consumers to take greater control over their healthcare finances.

AI Generated. May Contain Errors.

HealthEquity Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
76th Percentile Overall Score

HQY MarketRank™: 

HealthEquity scored higher than 76% of companies evaluated by MarketBeat, and ranked 150th out of 905 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    HealthEquity has received a consensus rating of Moderate Buy. The company's average rating score is 2.77, and is based on no strong buy ratings, 11 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside/Downside

    The consensus price target for HealthEquity is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    HealthEquity has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about HealthEquity's stock forecast and price target.
  • Earnings Growth

    Earnings for HealthEquity are expected to grow by 16.07% in the coming year, from $3.92 to $4.55 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of HealthEquity is 39.19, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 45.33.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of HealthEquity is 39.19, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 271.11.

  • Price to Earnings Growth Ratio

    HealthEquity has a PEG Ratio of 1.76. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    HealthEquity has a P/B Ratio of 4.24. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about HealthEquity's valuation and earnings.
  • Percentage of Shares Shorted

    6.12% of the float of HealthEquity has been sold short.
  • Short Interest Ratio / Days to Cover

    HealthEquity has a short interest ratio ("days to cover") of 6.01.
  • Change versus previous month

    Short interest in HealthEquity has recently decreased by 4.36%, indicating that investor sentiment is improving.
  • Dividend Yield

    HealthEquity does not currently pay a dividend.

  • Dividend Growth

    HealthEquity does not have a long track record of dividend growth.

  • News Sentiment

    HealthEquity has a news sentiment score of 1.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for HealthEquity this week, compared to 4 articles on an average week.
  • Search Interest

    Only 2 people have searched for HQY on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added HealthEquity to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, HealthEquity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,651,280.00 in company stock.

  • Percentage Held by Insiders

    1.60% of the stock of HealthEquity is held by insiders.

  • Percentage Held by Institutions

    99.55% of the stock of HealthEquity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about HealthEquity's insider trading history.
Receive HQY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HQY Stock News Headlines

HealthEquity (NASDAQ:HQY) Rating Lowered to "Hold" at Wall Street Zen
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel
HealthEquity's Earnings Momentum Deserves More Credit
Healthequity (HQY) Gets a Buy from Barclays
See More Headlines

HQY Stock Analysis - Frequently Asked Questions

HealthEquity's stock was trading at $91.61 at the beginning of the year. Since then, HQY shares have increased by 14.2% and is now trading at $104.63.

HealthEquity, Inc. (NASDAQ:HQY) issued its quarterly earnings results on Thursday, May, 28th. The company reported $1.24 earnings per share for the quarter, topping analysts' consensus estimates of $1.11 by $0.13. The firm's revenue was up 7.2% compared to the same quarter last year.
Read the conference call transcript
.

HealthEquity (HQY) raised $100 million in an initial public offering (IPO) on Tuesday, July 29th 2014. The company issued 9,100,000 shares at $10.00-$12.00 per share.

Top institutional investors of HealthEquity include BlackRock Inc. (13.49%), Wasatch Advisors LP (9.52%), Bank of New York Mellon Corp (0.80%) and Oppenheimer Asset Management Inc. (0.28%). Insiders that own company stock include Jon Kessler, Ian Sacks, Delano Ladd, Stephen Neeleman, Robert W Selander, Tyson D Murdock, Michael Henry Fiore, Larry L Trittschuh, Elimelech Rosner, Evelyn S Dilsaver, Gayle Furgurson Wellborn, Stuart B Parker and Frank Corvino.
View institutional ownership trends
.

Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that HealthEquity investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Netflix (NFLX), Palo Alto Networks (PANW) and Adobe (ADBE).

Company Calendar

Last Earnings
5/28/2026
Today
8/09/2026
Next Earnings (Estimated)
8/27/2026
Fiscal Year End
1/31/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Managed Healthcare
Current Symbol
NASDAQ:HQY
CIK
1428336
Employees
2,814
Year Founded
2002

Price Target and Rating

High Price Target
$128.00
Low Price Target
$89.00
Potential Upside/Downside
+6.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.77
Research Coverage
13 Analysts

Profitability

EPS (Trailing Twelve Months)
$2.67
Trailing P/E Ratio
39.19
Forward P/E Ratio
26.69
P/E Growth
1.76
Net Income
$215.20 million
Net Margins
17.25%
Pretax Margin
22.35%
Return on Equity
14.75%
Return on Assets
9.22%

Debt

Debt-to-Equity Ratio
0.46
Current Ratio
3.44
Quick Ratio
3.44

Sales & Book Value

Annual Sales
$1.34 billion
Price / Sales
6.54
Cash Flow
$5.28 per share
Price / Cash Flow
19.83
Book Value
$24.66 per share
Price / Book
4.24

Miscellaneous

Outstanding Shares
83,602,000
Free Float
82,264,000
Market Cap
$8.75 billion
Optionable
Optionable
Beta
0.21

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NASDAQ:HQY) was last updated on 8/9/2026 by MarketBeat.com Staff.
From Our Partners